Neurological Disorder Drugs Market Projected to Reach USD 125.60 Billion with Key Drivers, Size, Share, Growth and Opportunities by 2029

Data Bridge Market Research Published Latest Global Neurological Disorder Drugs Market Study by in-depth analysis about current scenario, the Market size, demand, growth pattern, trends, and forecast.

Neurological Disorder Drugs market research report is composed of myriad of factors that have an influence on the market and include industry insight and critical success factors (CSFs), market segmentation and value chain analysis, industry dynamics, market drivers, market restraints, key opportunities, technology and application outlook, country-level and regional analysis, competitive landscape, company market share analysis and key company profiles. In addition, businesses can gain insights into profit growth and sustainability programme with this report. Business intelligence is an essential aspect when it comes to accomplish thorough and wide-ranging market insights and the same is applied for producing Neurological Disorder Drugs market report.

Data Bridge Market Research analyses that the neurological disorder drugs market was valued at USD 79.40 billion in 2021 and is expected to reach USD 125.60 billion by 2029, registering a CAGR of 5.9% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download Sample To Understand The Complete Structure Of The Report @

Key Market Players mentioned in this report:

  • Merck KGaA (Germany)
  • Eisai Co., Ltd. (Japan)
  • AstraZeneca (U.K.)
  • Sanofi (France)
  • Novartis AG (Switzerland)
  • Abbott (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Teva Pharmaceutical Industries Ltd. (Ireland)
  • Pfizer Inc. (U.S.)
  • GlaxoSmithKline plc (U.K.)
  • WOCKHARDT (Mumbai)

An Global influential Neurological Disorder Drugs market document makes organization armed with data and information generated by sound research methods. This market analysis helps to get up to date about various segments that are relied upon to observe the rapid business development amid the estimate forecast frame. The market research report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as revenue, cost, and gross margin. Global Neurological Disorder Drugs business report plays very essential role when it is about achieving an incredible growth in the business.

Browse Full Report Along With Facts and Figures @

Global Neurological Disorder Drugs Market Scope:

The neurological disorder drugs market is segmented on the basis of indication, drug class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.


  • Epilepsy
  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Cerebrovascular Disease
  • Others

Drug Class

  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonists
  • Antiepileptic
  • Antipsychotic and Antidepressant
  • Others


  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Neurological Disorder Drugs Market, By Region:

The neurological disorder drugs market is analysed and market size insights and trends are provided by country, indication, drug class, route of administration, end-users and distribution channel as referenced above.

The countries covered in the neurological disorder drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the neurological disorder drugs market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the high prevalence of prevalence of neurological disorder and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, growing presence of major key players and increase in number of FDA approval drugs will further propel the market’s growth rate in this region.

Reasons to Buy This Report:

  • Save the time and resources required for entry level research by getting an insight into the leading players and segments of global Neurological Disorder Drugs market.
  • The report highlights key business priorities which will help companies to reform their business strategies and establish themselves in the global market.
  • The key findings and recommendations given in the report emphasize on crucial progressive industry trends in the Neurological Disorder Drugs Market thereby enabling players to develop effective long term strategies in order to garner their market revenue.
  • Gain crucial insights into global market trends and outlook and the factors driving and hindering market growth.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Inquire Before Buying This Research Report@

Neurological Disorder Drugs Market Dynamics:


Growing geriatric population

  • The market’s growth is propelled by an increase in the geriatric population, which leads to the presentation of numerous neurological problems. Cerebrovascular disorders such as stroke and migraine affect people of all ages in countries including Germany, the United Kingdom, and Italy. In adults aged 45 to 84, France, Sweden, Greece, Denmark, and Russia have high rates of cerebrovascular illness. As per a study published in the NCBI in 2018, the prevalence of stroke in Singapore was 7.67 percent among persons aged 65 and up.

Increasing investment for healthcare infrastructure

  • Another significant factor influencing the growth rate of dermatitis market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Rising awareness about early disease diagnosis

  • The neurological disorder drugs market is expected to grow due to rising awareness associated with early disease diagnosis through awareness campaigns by government regulatory bodies and private organizations, and market entry of efficient drugs in the near future, owing to the presence of a strong drug pipeline. As per a report published by the Pharmaceutical Research and Manufacturers of America (PhRMA) in April 2018, biopharmaceutical companies in the United States are currently developing 537 medications for various neurological illnesses. 95 drugs for brain tumors, 46 for chronic pain, and 92 for Alzheimer's disease are among them. Multiple sclerosis, migraines, amyotrophic lateral sclerosis, and Parkinson's disease are among the 30 illnesses being researched.

 Table of Contents: Global Neurological Disorder Drugs Market

1 Introduction
2 Market Segmentation
3 Executive Summary
4 Premium Insight
5 Market Overview
6 Covid-19 Impact on Neurological Disorder Drugs in Healthcare Industry
7 Global Neurological Disorder Drugs Market, by Product Type
8 Global Neurological Disorder Drugs Market, by Modality
9 Global Neurological Disorder Drugs Market, by Type
10 Global Neurological Disorder Drugs Market, by Mode
11 Global Neurological Disorder Drugs Market, by End User
12 Global Neurological Disorder Drugs Market, by Geography
13 Global Neurological Disorder Drugs Market, Company Landscape
14 Swot Analysis
15 Company Profiles
16 Questionnaire
17 Related Reports

Check Complete Table of Contents with List of Table and Figures @

Top Trending Related Reports of Healthcare Industry:-

Connected Healthcare Market – Global Industry Trends and Forecast to 2028

Healthcare Electronic Data Interchange (EDI) Market – Global Industry Trends and Forecast to 2028

Motion Capture Market Size, share, Trends, Analysis, Segmentation, & Forecast by 2029

Medical Marijuana Market – Global Industry Trends and Forecast to 2028

Healthcare Data Informatics Software Market – Global Industry Trends and Forecast to 2027.

Mammography Workstation Market Trends, Rising Opportunities, Size, Share, Segments and Revenue Forecast to 2028.

Drug Delivery Market Estimated to Reach USD 2800.61 Million with Size, Share, Demand, Trend, Latest Innovations & Application Analysis by 2029.

Urachal Cancer Market Demand, Growth Factors, Supply, Latest Rising Trend & Forecast to 2028.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475


Back to news